Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice - Concepedia

Concepedia

Publication | Closed Access

Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice

19

Citations

28

References

2020

Year

Elísabeth Pérez-Ruiz, Jerónimo Jiménez-Castro, Miguel‐Ángel Berciano‐Guerrero, Javier Valdivia, S. Estalella-Mendoza, Fátima Toscano, María Rodríguez de la Borbolla Artacho, Margarita Garrido-Siles, María José Martínez Bautista, Rosa Villatoro Roldán,

Clinical & Translational Oncology

Chronic Inflammatory DiseasesIntestinal Dysbiosis-related DrugsProbioticDysbiosisAutoimmune DiseaseMucosal ImmunologyImmune Checkpoint InhibitorsImmunologyGastroenterologyPathologyClinical PracticeGut BarrierIntestinal MicrobiotaMicrobiomeImmunotherapyMedicineUlcerative Colitis

References

	Year	Citations

Page 1

Page 1